FRA:AMG - US0311621009 - Common Stock
We assign a fundamental rating of 5 out of 10 to AMG. AMG was compared to 74 industry peers in the Biotechnology industry. AMG has an excellent profitability rating, but there are concerns on its financial health. AMG may be a bit undervalued, certainly considering the very reasonable score on growth
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.53% | ||
ROE | 89.11% | ||
ROIC | 14.12% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 31.3% | ||
PM (TTM) | 18.96% | ||
GM | 69.71% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 7.24 | ||
Debt/FCF | 4.94 | ||
Altman-Z | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.31 | ||
Quick Ratio | 0.98 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.05 | ||
Fwd PE | 12.87 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 13.46 | ||
EV/EBITDA | 12.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.33% |
FRA:AMG (9/1/2025, 9:33:14 AM)
244.2
-0.85 (-0.35%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.33% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.05 | ||
Fwd PE | 12.87 | ||
P/S | 4.39 | ||
P/FCF | 13.46 | ||
P/OCF | 12.76 | ||
P/B | 20.63 | ||
P/tB | N/A | ||
EV/EBITDA | 12.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.53% | ||
ROE | 89.11% | ||
ROCE | 16.21% | ||
ROIC | 14.12% | ||
ROICexc | 16.03% | ||
ROICexgc | 59.12% | ||
OM | 31.3% | ||
PM (TTM) | 18.96% | ||
GM | 69.71% | ||
FCFM | 32.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 7.24 | ||
Debt/FCF | 4.94 | ||
Debt/EBITDA | 3.25 | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | 250 | ||
Cash Conversion | 72.72% | ||
Profit Quality | 172.01% | ||
Current Ratio | 1.31 | ||
Quick Ratio | 0.98 | ||
Altman-Z | N/A |